ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Pennsylvania » Geriatric Medicine

Top Geriatric Medicine Prescribers in Pennsylvania

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DOROTHY CANDIB MD

Geriatric Medicine

7,265

$360K

235
234 are 65+

42%
patients receiving schedule two controlled substances

Avg: 14%

9%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $50

GARY BERNETT M.D.

Geriatric Medicine

3,757

$181K

72
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $50

PAUL MOYER M.D.

Geriatric Medicine

6,892

$356K

151
145 are 65+

17%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $50

ROGER ZIONCHECK M.D.

Geriatric Medicine

12,741

$581K

442
391 are 65+

14%
patients receiving schedule two controlled substances

Avg: 14%

19%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $50

ROBERT GORDON MD

Geriatric Medicine

14,092

$933K

249
241 are 65+

24%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$66
Average prescription price

Avg: $50

ROBERT PEARLSTEIN D.O.

Geriatric Medicine

103,576

$5.85M

2523
2127 are 65+

15%
patients receiving schedule two controlled substances

Avg: 14%

6%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $50

FAINA CAPLAN MD

Geriatric Medicine

11,440

$544K

328
319 are 65+

12%
patients receiving schedule two controlled substances

Avg: 14%

4%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $50

JOHN BAILEY D.O.

Geriatric Medicine

16,692

$722K

478
453 are 65+

12%
patients receiving schedule two controlled substances

Avg: 14%

18%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$43
Average prescription price

Avg: $50

RUSSELL RENTLER MD

Geriatric Medicine

7,196

$329K

269
258 are 65+

15%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $50

MARIAN BRYCE D.O.

Geriatric Medicine

17,741

$937K

662
554 are 65+

18%
patients receiving schedule two controlled substances

Avg: 14%

6%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $50

LOUIS PICCOLI MD

Geriatric Medicine

33,985

$196K

350
316 are 65+

15%
patients receiving schedule two controlled substances

Avg: 14%

13%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 24%

$6
Average prescription price

Avg: $50

RITA REICHARD MD

Geriatric Medicine

10,844

$670K

318
278 are 65+

27%
patients receiving schedule two controlled substances

Avg: 14%

4%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $50

MARY MUSUKU M.D

Geriatric Medicine

5,549

$275K

257
198 are 65+

19%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $50

DANIEL HAIMOWITZ MD

Geriatric Medicine

12,396

$537K

354
340 are 65+

8%
patients receiving schedule two controlled substances

Avg: 14%

11%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$43
Average prescription price

Avg: $50

ANNE YAWMAN MD

Geriatric Medicine

4,044

$268K

149
148 are 65+

9%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$66
Average prescription price

Avg: $50

UMESH GOLANI MD

Geriatric Medicine

22,762

$1.13M

629
477 are 65+

17%
patients receiving schedule two controlled substances

Avg: 14%

17%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $50

SUSAN SCHWARTZ M. D.

Geriatric Medicine

5,809

$348K

131
109 are 65+

19%
patients receiving schedule two controlled substances

Avg: 14%

13%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$60
Average prescription price

Avg: $50

WARD BECKER M.D.

Geriatric Medicine

8,877

$415K

234
230 are 65+

18%
patients receiving schedule two controlled substances

Avg: 14%

9%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $50

CATHERINE GRUER MD

Geriatric Medicine

6,803

$320K

161
126 are 65+

32%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $50

NAMITA AHUJA MD

Geriatric Medicine

6,440

$299K

220
212 are 65+

20%
patients receiving schedule two controlled substances

Avg: 14%

14%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $50

MONICA SETHI MD

Geriatric Medicine

1,993

$98K

117
89 are 65+

33%
patients receiving schedule two controlled substances

Avg: 14%

11%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $50

PRIYA VASDEV M.D.

Geriatric Medicine

20,631

$1.59M

620
483 are 65+

26%
patients receiving schedule two controlled substances

Avg: 14%

6%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$77
Average prescription price

Avg: $50

ROBERT FURIA MD

Geriatric Medicine

6,116

$326K

187
168 are 65+

19%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $50

MICHELLE SCANNAPIECO MD

Geriatric Medicine

16,363

$939K

419
395 are 65+

13%
patients receiving schedule two controlled substances

Avg: 14%

12%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $50

WILLIAM ZIRKER MD

Geriatric Medicine

7,219

$372K

223
203 are 65+

13%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $50

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank